ArticlePloS one2026
Genomic and chemical insights into a human lectin-binding extracellular polysaccharides from Parageobacillus toebii strain H-70.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular polysaccharides (EPSs) from thermophilic bacteria are promising biopolymers due to their stability and structural variability. This study aimed to characterize the genomic and chemical features of EPS produced by Parageobacillus toebii strain H-70 isolated from a geothermal spring in Armenia. EPS from strain H-70 was produced in sucrose and glucose based medium and analyzed chemically by TLC, HPAEC-PAD, GC-MS, and NMR. Protein, uronic acid, and nucleic acid contents were quantified by spectrophotometric methods. Molasses, an inexpensive byproduct of sugar production, was used as the carbon source too. Whole-genome sequencing, comparative phylogenomics, and genome mining were performed to identify biosynthetic gene clusters, carbohydrate-active enzymes (CAZymes), and regulatory components associated with EPS metabolism. Strain H-70 yielded 37.9 mg/L EPS (0.10 g/g dry cell weight) after 72 h cultivation at 55 °C and pH 7.0 with sucrose as sole carbon source. The EPS was a heteropolysaccharide composed of rhamnose, glucose, galactose, and mannose, along with proteins (15.04%), uronic acids (4.22%), and nucleic acids (4.88%). The EPS yield obtained with glucose as the sole carbon source was 10.5 mg/L, whereas molasses supplementation resulted in a yield of 14.5 mg/L. The draft genome (~3.2 Mb, 42% G + C, 98.9% ANI with P. toebii DSM 14590) encoded five Wzy-dependent EPS gene clusters with glycosyltransferases, transporters, and regulators. The genome also carried diverse CAZymes (GH, GT, CE, CBM, AA families) and modification enzymes (e.g., CsaB, acetyltransferases), indicating structural and functional variability of the polymer. In addition, the binding to human C-type lectins (carbohydrate-binding proteins involved in innate and adaptive immune-responses) has been studied by solid-phase assay. This study provides the first comprehensive characterization of EPS from P. toebii H-70, integrating genomic and chemical insights. The binding to human C-type lectins offers future EPSs biomedical applications especially in as immune-modulators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.